Bruker (BRKR) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.74 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.69%. A quarter ago, it was expected that this scientific equipment maker would post earnings of $0.63 per share when it actually produced earnings of $0.74, delivering a surprise of 17.46%.Over the last four quarters, the ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Bruker (BRKR) , which belongs to the Zacks Instruments - Scientific industry, could be a great candidate to consider.When looking at the last two reports, this scientific equipment maker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 10.81%, on average, in the last two quarters.For the most recent qua ...

Investors are always looking for stocks that are poised to beat at earnings season and Bruker Corporation (BRKR) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Bruker is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good ind ...

OSAKA, Japan--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Nanophoton Corporation, a pioneer focused on advanced research Raman microscopy systems. Headquartered in Osaka, Nanophoton offers a broad portfolio of advanced Raman microscopes, serving academic and industrial research customers, primarily in Japan. This acquisition fills a gap in Bruker’s molecular microscopy portfolio, and Bruker is looking forward to offering fast, flexible and sensitive Nanophoton Raman ...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2023 financial results before market opening on Tuesday, February 13, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q4 2023 Earnings Webcast” hyperlink in the “Events & Presentations” section. ...

BOSTON--(BUSINESS WIRE)--At the SLAS2024 International Conference and Exhibition, Bruker Corporation (Nasdaq: BRKR) today introduced the ground-breaking, new ‘Triceratops’ SPR #64 Surface Plasmon Resonance (SPR) instrument. The SPR #64 system has been engineered from the bottom up to accelerate drug discovery with increased SPR throughput, leading sensitivity and data quality. In modern drug discovery, SPR is indispensable for the real-time, label-free biophysical characterization of molecular interactions. ...

Bruker Corporation (BRKR) recently entered into a definitive agreement to acquire a Swiss provider of vendor-agnostic automated laboratory R&D and QC workflow solutions, Chemspeed Technologies AG. This marks a significant stride into the realm of lab automation, digitalization, and scientific software solutions.This strategic move positions Bruker to further strengthen its Project Accelerate 2.0 initiative, which is focused on “Assays, Software, and Aftermarket.”Accelerating Entry Into AutomationChemspeed T ...

BASEL, Switzerland--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced a definitive agreement for the acquisition of Chemspeed Technologies AG, a Swiss provider of vendor-agnostic automated laboratory R&D and QC workflow solutions. Chemspeed is focused on modular automation and robotics solutions for chemical research, pharma drug formulation, materials research for cleantech and consumer applications. The Chemspeed acquisition accelerates Bruker’s entry into lab automation, digitalizatio ...

ZURICH & NEWTON, Massachusetts--(BUSINESS WIRE)--Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today the operational readiness of its new proteomics facility in Massachusetts. This US expansion facilitates access to select proteomics contract research organization (CRO) services for our US biopharma customers. The Massachusetts facility will initially focus on TrueDiscovery® data-independent acquisition (DIA) discovery proteomics services that o ...

Bruker Corporation (BRKR) is likely to grow in the coming quarters due to the solid prospects of the Bruker Scientific Instruments (“BSI”) Nano and BioSpin group. The addition of PhenomeX complements the Bruker cellular and sub-cellular analysis tools and brings opportunities for commercial synergies.However, BRKR’s operations are subject to intense competition from its peers in the industry.In the past year, this Zacks Rank #3 (Hold) stock has increased 5% against the 14.2% fall of the industry and a 22.6% ...